# PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

> **NCT06758024** · NA · RECRUITING · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 72 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Crohn Disease (CD)
- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT06758024
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-24
- **Primary completion:** 2026-01
- **Final completion:** 2027-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06758024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06758024, "PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06758024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*